Hematologic Malignancy
Prefibrotic Primary Myelofibrosis
CI-CAN-00008289Explore in graph →
Hematologic3 active trials
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00008289Explore in graph →
Clinical trials
8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04942080 | Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)(CALRSUIVI) | recruiting | N/A | 260 | University Hospital, AngersOTHER_GOV | 1 | Mar 6, 2026 | clinicaltrials |
| NCT03869476 | Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.(BioScoreSMP) | completed | N/A | 133 | University Hospital, AngersOTHER_GOV | 1 |
| Dec 30, 2024 |
| clinicaltrials |
| NCT03121599 | 18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms | terminated | N/A | 3 | Hamad Medical CorporationINDUSTRY | 1 | Aug 11, 2020 | clinicaltrials |
Data updated 22 days agoSource updated Mar 6, 2026source: clinicaltrials